Skip to main content
    I

    Inogen Inc (INGN)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $5.68
    +0.05 (+0.98%)

    Market Cap: $147.95M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Inogen Inc (INGN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Inogen (INGN) has a market cap of $147.95M and an enterprise value of $66.11M. It holds $81.84M more cash than debt, 55.32% of its market cap. Its share count is down 2.27% from a year earlier.

    Total Valuation

    Enterprise value is 55.32% below the market cap, as cash exceeds debt.

    Market Cap$147.95M
    Enterprise Value$66.11M
    Latest price (Nov 17, 2026)$5.68

    Key Dates

    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 2.16% in the quarter ended Sep 30, 2026 and grew 5.55% a year over 2 years.

    Shares Outstanding26.46M
    Shares Change (YoY)-2.27%
    Shares Change (QoQ)-2.16%
    Share Count Growth (2Y CAGR)+5.55%

    Valuation Ratios

    Sales and book value multiples are 0.4x and 1.0x. Its year-end P/S ranged from 0.4x to 10.0x from 2016 to 2025.

    P/S Ratio0.4x
    Forward P/S0.5x
    P/B Ratio1.0x
    P/TBV Ratio1.1x

    Valuation history and multiples

    Price Statistics

    The stock is down 17.61% over 52 weeks and trades 5.49% below its 50-day average.

    Beta (1Y)0.59
    52-Week Change-17.61%
    1-Month Change-13.21%
    3-Month Change+0.09%
    6-Month Change-11.86%
    5-Year Change-82.70%
    10-Year Change-87.22%
    Total Return (1Y)-17.61%
    Total Return (3Y CAGR)-0.32%
    Total Return (5Y CAGR)-30.09%
    Return vs SPY (1Y)-28.57%
    Max Drawdown (1Y)-30.75%
    Max Drawdown (3Y)-60.79%
    Sharpe Ratio (1Y)-0.41
    Correlation with SPY (1Y)0.18
    50-Day Average$6.01
    200-Day Average$6.23
    52-Week Range$5.04 to $7.67
    RSI (14 Days)37.2
    Average Volume (20 Days)298.27K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.96x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio2.96x
    Quick Ratio2.55x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -22.59% over the last 12 months, against a 5-year average of -22.47%.

    Return on Equity (ROE)-22.59%
    Return on Assets (ROA)-13.38%
    ROE (5Y Average)-22.47%
    ROA (5Y Average)-14.62%
    ROIC (5Y Average)-14.05%
    Asset Turnover1.19x
    Inventory Turnover6.55x
    Receivables Turnover7.16x
    Cash Conversion Cycle29 days

    Scores

    INGN has an Altman Z-Score of 1.19, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score1.19
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $339.11M over the last 12 months is up 1.61% from the 12 months before.

    Revenue$339.11M
    Revenue Growth (YoY)+1.61%
    Gross Profit$150.38M
    Operating Income-$39.32M
    Pretax Income-$34.51M
    Net Income-$35.46M
    EBITDA-$26.61M
    Reported EPS (TTM)-$0.99

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 59.26% of the $264.91M in total assets.

    Cash and Equivalents$81.84M
    Total Debt$0
    Net Cash$81.84M
    Net Cash Per Share$3.09
    Working Capital$138.06M
    Shareholder Equity$156.99M
    Book Value Per Share$5.93
    Tangible Book Value$130.91M
    Tangible Book Per Share$4.95
    Total Assets$264.91M
    Total Liabilities$107.92M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $2.18M of capital spending, operating cash flow left -$11.33M of free cash flow.

    Operating Cash Flow-$9.15M
    Capital Expenditures$2.18M
    Free Cash Flow-$11.33M
    FCF Per Share-$0.43
    Depreciation and Amortization$17.63M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -11.60%, against a 5-year average of -15.20%.

    Gross Margin44.35%
    Operating Margin-11.60%
    Pretax Margin-10.18%
    Net Margin-10.46%
    EBITDA Margin-7.85%
    FCF Margin-3.34%
    Gross Margin (5Y Average)44.09%
    Operating Margin (5Y Average)-15.20%
    Net Margin (5Y Average)-14.73%

    Growth

    Revenue fell 2.59% a year over 3 years.

    Revenue Growth (3Y CAGR)-2.59%
    Revenue Growth (5Y CAGR)+2.48%
    Book Value Per Share Growth (2Y CAGR)-10.27%
    Tangible Book Per Share Growth (2Y CAGR)-10.14%

    Revenue and profit by year

    Dividends and Yields

    INGN does not pay a dividend. Its free cash flow yield is -7.53%.

    FCF Yield-7.53%
    Buyback Yield6.99%
    Shareholder Yield6.99%

    Peer Position

    Against 12 similar companies, INGN has the 12th highest P/S.

    P/S Ratio0.4x vs 2.3x median
    Revenue Growth (Trailing 4 Quarters, YoY)+1.61% vs +13.76% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -6.02% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-6.02%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About INGN

    What is INGN's market cap?

    Inogen has a market cap of $147.95M. Its enterprise value, which adds debt and subtracts cash, is $66.11M.

    How many shares of INGN are outstanding?

    Inogen has 26.46M shares outstanding. The count is down 2.27% from a year earlier.

    Does INGN pay a dividend?

    No. Inogen does not pay a dividend.

    How much debt does INGN have?

    Inogen has $0 of total debt and $81.84M of cash and equivalents, a net cash position of $81.84M.